Brazil Launches Amazon Vaccination Rush Amid Virus Surge
Brazil’s Amazonas state launches urgent COVID-19 vaccination drive as hospitals reach capacity, highlighting challenges in protecting remote communities.
PublicHealth
Read More
U.S. COVID Trends Shift: Variants Rise as Cases Decline Nationwide
U.S. COVID cases decline in 49 states as variants emerge, with California reporting a 32% drop in infections. New Hampshire sees an uptick amid vaccine progress.
U.S. Health Officials Battle Politics Amid Pandemic Pushback
U.S. health departments face political resistance and staff burnout as COVID-19 policies spark clashes between public safety mandates and individual freedoms.
Global COVID-19 Cases Surpass 100 Million as Death Toll Climbs
Global COVID-19 infections exceed 100 million with over 2 million deaths, highlighting ongoing challenges in pandemic management.
U.S. Nears 400K COVID Deaths as Biden Prepares Aggressive Strategy
As U.S. COVID-19 deaths near 400,000, President-elect Biden outlines a vaccine-driven strategy to combat the pandemic’s peak.
U.S. Intensifies Tracking of New COVID-19 Variant as Spread Suspected Wider
U.S. health authorities escalate tracking of a fast-spreading COVID-19 variant, urging public vigilance amid concerns over undetected transmission.
Brazil’s Beaches Packed Amid Rising COVID-19 Concerns
Brazil faces a new COVID-19 surge as beaches overflow with crowds ignoring safety protocols, sparking public health warnings.
LA Streets Under Lockdown: A Snapshot of COVID-19’s Surge
Los Angeles battles surging COVID-19 cases amid lockdowns, revealing stark contrasts between vacant tourist zones and vulnerable communities struggling to cope.
Mexico Launches COVID-19 Vaccination Campaign with Frontline Heroes
Mexico initiates its COVID-19 vaccination campaign with nurse Maria Irene Ramirez as the first recipient, addressing the highest healthcare worker death rate in the country.
US Advances COVID-19 Response with New Rapid Test and Vaccine Approval
The U.S. FDA approves a new at-home rapid COVID-19 test and is set to approve Moderna’s second vaccine, aiming to immunize 20 million Americans by December.